Keywords: alza, corp, acquires, marketing, rights, flexeril, merck

Alza Corp acquires marketing rights to Flexeril from Merck & Co

Article | 06 February 2001

Print This

Alza Corp has acquired marketing rights to Merck & Co's muscle relaxantFlexeril (cyclobenzaprine), which the former hopes to combine with a ...

Enjoying this article? To continue reading you need to login or subscribe.

Subscribe now
for unlimited access to all articles

Subscriptions are £60 per month, pay as you go.
Find out more details.

Already a subscriber? Click here to log in